Argenx
ARGX
#402
Rank
ยฃ44.49 B
Marketcap
ยฃ707.62
Share price
-1.73%
Change (1 day)
0.83%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): ยฃ16.86

According to Argenx 's latest financial reports the company's current EPS (TTM) is ยฃ17.09. In 2025 the company made an earnings per share (EPS) of ยฃ16.11 an increase over its 2024 EPS that were of ยฃ10.64.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ16.864.65%
2025ยฃ16.1151.44%
2024ยฃ10.64-369.77%
2023-ยฃ3.94-60.46%
2022-ยฃ9.9863.33%
2021-ยฃ6.11-40.37%
2020-ยฃ10.24183.47%
2019-ยฃ3.61123.09%
2018-ยฃ1.6254.93%
2017-ยฃ1.0514.07%
2016-ยฃ0.9213.05%
2015-ยฃ0.81-36.34%
2014-ยฃ1.27209.04%
2013-ยฃ0.41-33.99%
2012-ยฃ0.62185.59%
2011-ยฃ0.22